Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL, Aharony D, Bialecki RA, Abbott BM, Barthlow HG, Caccese R, Ghanekar S, Lengel D, McCarthy M, Wenrich B, Undem B, Ohnmacht C, Shenvi A, Albert JS, Brown F, Bernstein PR, Russell K.
Rumsey WL, et al. Among authors: wenrich b.
J Pharmacol Exp Ther. 2001 Jul;298(1):307-15.
J Pharmacol Exp Ther. 2001.
PMID: 11408556